Biofrontera AG

BST:B8FE Stock Report

Market Cap: €89.9m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Biofrontera Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure2.3yrs
Board average tenureless than a year

Recent management updates

Recent updates

CEO

Biofrontera has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Ludwig Lutter
Member of the Executive Board1.8yrs€333.20kno data
Pilar de la Huerta
Chief Financial Officerless than a yearno datano data
Pamela Keck
Head of Investor Relationsno datano datano data
Alexander Richardson
Head of UK Sales Team4.6yrsno datano data
Matthias Naumann
Head of Sales & Marketing - Europe2.9yrsno datano data

2.3yrs

Average Tenure

Experienced Management: B8FE's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Humphrey Rang
Head of the Scientific Advisory Boardno datano datano data
Wilhelm Zours
Chairman of the Supervisory Boardless than a year€2.00kno data
Heikki Lanckriet
Member of the Supervisory Boardless than a year€3.00kno data
Helge Lubenow
Member of the Supervisory Boardless than a year€3.00kno data
Karlheimz Schmelig
Member of the Supervisory Boardless than a year€3.00kno data
Jorgen Thielmann
Vice-Chairman of the Supervisory Boardless than a year€3.00kno data
Karin Lergenmuller
Member of Supervisory Boardless than a yearno datano data

1.0yrs

Average Tenure

53yo

Average Age

Experienced Board: B8FE's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/12/06 02:32
End of Day Share Price 2022/09/08 00:00
Earnings2022/09/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biofrontera AG is covered by 9 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Raymond MyersBenchmark Company
Navid MalikCavendish Historical (Cenkos Securities)
Robert WassermanDawson James Securities